High efficacy and low toxicity of APL induction with concurrent idarubicin/ATRA followed by a novel and simplified outpatient post-remission therapy using single doses of idarubicin and intermittent ATRA

Author: Aljurf M.   Al Qurashi F.   Al Mohareb F.   Sahovic E.   Al Sharif F.   Al Zahrani H.   Al Shanqeeti A.   Owaidah T.   Iqbal A.   Zaidi S.   Nurgat Z.   Sanz M.   Chaudhri N.  

Publisher: Humana Press, Inc

ISSN: 1357-0560

Source: Medical Oncology, Vol.27, Iss.3, 2010-09, pp. : 702-707

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content